a complete understanding of the function of the ten-eleven translocation (tet) family of dioxygenase-mediated Dna demethylation requires new methods to quantitatively map oxidized 5-methylcytosine (5mc) bases at high resolution. We have recently developed a methylase-assisted bisulfite sequencing (MaB-seq) method that allows base-resolution mapping of 5-formylcytosine (5fc) and 5-carboxylcytosine (5cac), two oxidized 5mc bases indicative of active Dna demethylation events. In standard bisulfite sequencing (Bs-seq), unmodified c, 5fc and 5cac are read as thymine; thus 5fc and 5cac cannot be distinguished from c. In MaB-seq, unmodified c is enzymatically converted to 5mc, allowing direct mapping of rare modifications such as 5fc and 5cac. By combining MaB-seq with chemical reduction of 5fc to 5hmc, we also developed caMaB-seq, a method for direct 5cac mapping. compared with subtraction-based mapping methods, MaB-seq and caMaB-seq require less sequencing effort and enable robust statistical calling of 5fc and/or 5cac. MaB-seq and caMaB-seq can be adapted to map 5fc/5cac at the whole-genome scale (WG-MaB-seq), within specific genomic regions enriched for enhancer-marking histone modifications (chromatin immunoprecipitation (chIp)-MaB-seq), or at cpG-rich sequences (reduced-representation (rr)-MaB-seq) such as gene promoters. the full protocol, including Dna preparation, enzymatic treatment, library preparation and sequencing, can be completed within 6-8 d.
IntroDuctIon
DNA cytosine methylation is an evolutionarily conserved epigenetic modification, and it is indispensable for normal mammalian development 1, 2 . Enzyme-catalyzed active DNA demethylation contributes substantially to dynamic regulation of the DNA methylome during development and in diseases. In mammals, active DNA demethylation (converting 5mC back to C) is initiated primarily by the enzymatic activity of the TET family of 5mC dioxygenases [3] [4] [5] . TET proteins convert 5mC into 5-hydroxymethylcytosine (5hmC) [6] [7] [8] . Further oxidative modification of 5hmC by TET proteins results in 5fC and 5caC 9, 10 , both of which can be efficiently excised by thymine DNA glycosylase (TDG) and restored to unmodified cytosines through the base-excision repair pathway ( Fig. 1 ) 5, 9, 11 . Genetic analyses of mutant mice deficient in TET proteins indicated that these enzymes have essential roles in a wide range of biological processes, including gene regulation [12] [13] [14] [15] [16] [17] [18] , embryonic development [19] [20] [21] , stem cell differentiation 8, 22, 23 , meiotic gene control 24 , erasure of genomic imprinting 19, 25 , learning and memory [26] [27] [28] , and cancer 29, 30 .
The TET/TDG-dependent active demethylation pathway involves the generation and excision repair of 5fC/5caC, and it may occur in both proliferating and postmitotic cells. Besides acting as intermediates of the active DNA demethylation pathway, oxidized methylcytosines may also possess unique regulatory functions 31, 32 . Recent studies have identified potential reader proteins for oxidized methylcytosines, many of which are transcription factors, chromatin-modifying enzymes or proteins linked to DNA repair processes [33] [34] [35] . Furthermore, accumulated 5fC and 5caC within gene bodies may have a regulatory role in decreasing the elongation rate of RNA polymerase II (refs. 36,37) . Finally, clustered 5fCpG sites have recently been shown to affect basepairing and DNA structure in vitro 38, 39 , and they may thus affect DNA-templated processes by directly modulating DNA conformation. A better mechanistic understanding of these potential regulatory roles of 5fC and 5caC requires the ability to systematically map the genomic position and determine absolute levels of these oxidized methylcytosines in the mammalian genome. Here we present detailed protocols for the MAB-seq method that we recently developed for single-base-resolution mapping of 5fC and 5caC (ref. 40) , as well as for caMAB-seq, a modified version of MAB-seq for direct 5caC mapping 40 .
Development of MAB-seq
Identification of cytosines that are committed to active DNA demethylation requires quantitative measurement of TDG-mediated excision of 5fC/5caC at high resolution. In addition, because both 5fC and 5caC are excised by TDG, strand-specific preference of active DNA demethylation activity requires simultaneous mapping of 5fC and 5caC in a single experiment. Recent studies using either modification-specific antibodies or chemical tagging have shown that genomic regions that are enriched for cytosines undergoing TET/TDG-dependent active demethylation can be identified via analysis of the ectopic accumulation of 5fC/5caC in Tdg-depleted cells 41, 42 . However, 5fC and 5caC maps generated by affinity-enrichment methods are of limited resolution (a few hundred base pairs). In addition, these 5fC and 5caC profiles represent only relative enrichment and lack strand distribution information. To circumvent these limitations, we have developed MAB-seq, a modified BS-seq strategy that allows simultaneous and quantitative mapping of both 5fC and 5caC at single-base resolution 40, 43 . In traditional BS-seq, C, 5fC and 5caC are efficiently deaminated through sodium bisulfite treatment, and all are read as thymine (T) in subsequent sequencing experiments. In contrast, 5mC and 5hmC are resistant to this chemical conversion and are read as C. In MAB-seq, genomic DNA is first treated with the bacterial DNA CpG methyltransferase M.SssI, which is an enzyme (originally isolated from Spiroplasma sp. strain MQ1)
Base-resolution profiling of active DNA demethylation using MAB-seq and caMAB-seq that efficiently methylates cytosines within CpG dinucleotides. Bisulfite conversion of M.SssI-treated DNA deaminates only 5fC and 5caC; originally unmodified C within CpGs becomes resistant to bisulfite conversion because of its conversion to 5mC. Subsequent sequencing will identify 5fC and 5caC as T, whereas C, 5mC and 5hmC are read as C (Fig. 1) . We have also developed a method termed caMAB-seq (5caC methylase-assisted bisulfite sequencing) to directly map 5caC at single-base resolution. In this modified version of MAB-seq, 5fC is first reduced by NaBH 4 to 5hmC. Owing to the combination of NaBH 4 reduction with M.SssI treatment, 5caC is sequenced as T after bisulfite conversion, whereas C, 5mC, 5hmC and 5fC are read as C.
Application and limitations of MAB-seq
A major advantage of the MAB-seq method is that it allows for direct and simultaneous mapping of 5fC and 5caC, which requires less sequencing effort and enables quantitative detection of all TET/TDG-dependent DNA demethylation events in a single experiment at single-base resolution. MAB-seq is also amenable to both genome-scale and locus-specific analyses (Fig. 2) . For instance, MAB-seq has been used to study both early embryos and mouse embryonic stem cells (ESCs), and it generated a whole-genome map of 5fC/5caC, as well as a quantitative profile of 5fC/5caC at specific loci 40, 43, 44 . The detection limit of MAB-seq is governed by several factors, including the error rate of the M.SssI methylase, the efficiency of bisulfite conversion of 5fC/5caC, the abundance of 5fC/5caC at the modified base, and overall sequencing depth. With the protocol described here, highly efficient conversion of C to 5mC and deamination of 5fC/5caC in genomic DNA can be achieved. Thus, sequencing depth is a major factor for sensitive and specific detection of 5fC/5caC by MAB-seq. However, MAB-seq is unable to distinguish 5fC/5caC from unmodified C within a non-CpG context because of the poor methylase activity of M.SssI toward C outside CpG dinucleotides. This limitation does not greatly affect the application of this technique for the following two reasons. First, whole-genome base-resolution mapping indicates that 5hmC is found almost exclusively in the CpG context (>99% in CpGs), even in mouse ESCs and neurons, in which non-CpG methylation is prevalent 45, 46 . Second, TET proteins have a strong preference for 5mC within the CpG context compared with that in the non-CpG context 47, 48 . Thus, 5mC within CpG dinucleotides is the primary target for TET proteins, and MAB-seq allows quantitative measurement of the abundance of 5fC/5caC within the CpG context.
Comparison of MAB-seq with other base-resolution 5fC or 5caC mapping methods
Both bisulfite-based and bisulfite-free mapping methods have been developed for mapping oxidized methylcytosines at single-base resolution (Fig. 3) 32 . Bisulfite-free base-resolution mapping methods, such as Pvu-Seal-seq 49 and fC-CET 50 , currently BS-seq: directly map 5mC/5hmC as C signal. MAB-seq: 1. Directly map 5fC/5caC as T signal. 2. Map unmodified C by subtracting 5mC + 5hmC (C signal in BS-seq) from C + 5mC + 5hmC (C signal in MAB-seq).
caMAB-seq: 1. Directly map 5caC as T signal. 2. Map 5fC by subtracting 5caC (T signal in caMAB-seq) from 5fC + 5caC (T signal in MAB-seq).
M.SssI 5fC
Bisulfite sequencing and its derivatives to generate three oxidized methylcytosines: 5hmC, 5fC and 5caC. Highly oxidized cytosine bases, 5fC and 5caC, are enzymatically excised by thymine DNA glycosylase (TDG), and the resulting abasic sites are repaired by the base-excision repair (BER) pathway to regenerate unmodified C, completing the DNA demethylation process (5mC to C). In standard bisulfite sequencing (BS-seq), 5mC and 5hmC are resistant to sodium-bisulfite-mediated deamination and are read as C in subsequent sequencing, whereas unmodified C, 5fC and 5caC are read as T. M.SssI exhibits robust methylase activity toward unmodified cytosines within CpGs. In MAB-seq, only 5fC and 5caC are read as T after genomic DNA is treated with M.SssI. In caMABseq, genomic DNA is first treated with sodium borohydride (NaBH 4 ) to reduce 5fC back to 5hmC, enabling 5caC to be directly mapped as T.
Sample collection and pre-processing DNA purification and enzymatic treatment for three genome-scale assays
Steps: 1-5
Step: 6A-C provide only relative enrichment of cytosines marked by 5fC. Compared with bisulfite-free methods, a major advantage of bisulfite-based mapping methods (including MAB-seq and caMAB-seq) is their ability to determine both base-resolution location and absolute levels of 5fC or 5caC. Before MAB-seq 40, 43 , several bisulfite-based mapping methods were developed that use specific chemical treatment to protect 5fC (fCAB-seq 41 and redBS-seq 51 ) or 5caC (caCAB-seq 52 ) from bisulfite-induced deamination. However, these methods require subtraction of the C signals between standard BS-seq and those of modified BS-seq to determine the position and abundance of 5fC or 5caC, thereby doubling the required sequencing effort. In addition, MAB-seq is the only method that is capable of detecting 5fC and 5caC simultaneously, which is required for base-resolution analysis of the strand-specificity of TET/TDG-mediated active DNA demethylation events. Moreover, MAB-seq and caMABseq can be integrated to map 5fC and 5caC together (MAB-seq), 5fC individually (by subtracting caMAB-seq from MAB-seq) and 5caC individually (caMAB-seq) at single-base resolution. Thus, with two genome-scale mapping experiments (MAB-seq plus caMAB-seq), this integrated approach not only provides quantitative base-resolution mapping of active DNA demethylation events (generation and excision of 5fC/5caC) but also distinguishes 5fC from 5caC at base resolution.
Experimental design
Enzymatic treatment ( Step 6A (iv, v, xi, xii) and Step 6C (v, vi)). Because incomplete methylation of unmodified CpGs will result in false positive 5fC/5caC signals, the conditions of the enzymatic treatment with M.SssI are critical to the success of MAB-seq. S-adenosylmethionine (SAM) is unstable at 37 °C and is sensitive to degradation at elevated pH (i.e., pH 7.5). Moreover, S-adenosylhomocysteine, the byproduct of the methylation reaction, binds more tightly to M.SssI than does SAM, and it greatly reduces the methylation reaction rate as time passes. Thus, it is important to ensure that only fresh SAM is used, as cofactors in the enzymatic reaction and the addition of more SAM after 2 h can increase the methylation rate. Because a high concentration of input DNA leads to the accumulation of high amounts of S-adenosylhomocysteine, we recommend that the concentration of input DNA does not exceed 20 ng/µl. M.SssI is more processive in the absence of magnesium and more distributive in the supplied reaction buffer (NEBuffer2 contains 10 mM MgCl 2 ). To maximize the methylation rate, we recommend treating genomic DNA in Mg 2+ -free buffer for one round and in the supplied reaction buffer for the second round. NaBH 4 reduction of 5fC to 5hmC ( Step 6C(ii, iii)). Several studies have shown that NaBH 4 can efficiently reduce 5fC to 5hmC, which changes the behavior of 5fC during bisulfite sequencing and offers a strategy for 5fC mapping 40, 41, 49, 51 . In caMAB-seq, a step of NaBH 4 reduction is added before M.SssI treatment. In our hands, this reduction step is compatible with M.SssI treatment and library preparation based on a reduced-representation bisulfite sequencing (RRBS) strategy 53 . We termed this method for genome-scale direct mapping of 5caC RR-caMAB-seq (Step 6C).
Bisulfite conversion of 5fC/5caC ( Step 6A(xiv-xvi) and
Step 6C(xiii)). Unlike unmodified C and 5caC (deamination rate >99%), converting 5fC to uracil by bisulfite treatment is less efficient 51 . We have optimized the bisulfite conversion conditions using different concentrations of sodium bisulfite (the Epitect Fast kit provides a much higher concentration of TAB-seq: directly map 5hmC as C, and map 5mC after subtraction from BS-seq fCAB-seq or redBS-seq: map 5fC after subtracting BS-seq oxBS-seq: directly map 5mC as C, and map 5hmC after subtraction from BS-seq caCAB-seq: map 5caC after subtracting BS-seq BS-seq: directly map 5mC/5hmC as C Genomic DNA MAB-seq: directly map 5fC/5caC as T, and map unmodified C after subtracting BS-seq caMAB-seq: directly map 5caC as T, and map 5fC after subtracting MAB-seq
Pvu-Seal -seq sodium bisulfite reagent than does the standard Epitect kit) and various incubation times. With the optimized bisulfite conversion protocol described in Table 1 (standard Epitect + 10 h treatment), ~85% of 5fC can be deaminated with minimal conversion of 5mC or 5hmC (measured by methylated lambda DNA or modificationspecific synthetic oligonucleotides).
Quality controls.
To assess the methylation rate within the CpG context, we use unmethylated lambda DNA as a spike-in control in both genome-wide and locus-specific MAB-seq experiments (Box 1).
To assess the behavior of oxidized bases (5hmC/5fC/5caC) in experiments for optimizing/validating reagents and conditions, we use modification-specific 38-mer synthetic double-stranded oligonucleotides containing nine CpG sites (Box 2). Validation of bisulfite treatment reagents via measurement of the deamination rate of unmodified cytosine can be performed along with MAB-seq experiments, and the bisulfite conversion rate of unmodified cytosine is ~99.5% under optimal experimental conditions. Enrichment strategy ( Step 6B and C). Whole-genome (WG) maps of 5fC and 5caC can be generated by the application of MAB-seq analysis to unenriched genomic DNA (WG-MAB-seq;
Step 6A). However, WG-MAB-seq is sequencing-intensive, and it can be cost-prohibitive for samples with relatively low levels of 5fC/5caC. To reduce sequencing efforts, enrichment strategies can be integrated with the MAB-seq workflow to generate genomescale maps. By combining ChIP with MAB-seq (ChIP-MAB-seq), one can examine 5fC/5caC abundance within a fraction of the genome where 5fC/5caC marks tend to be enriched ( Step 6B) 40 . In addition to histone antibodies, DNA immunoprecipitation using antibody to 5fC and/or 5caC could also be used to first enrich DNA fragments containing these rare modified bases before MAB-seq analysis (H. Wu and Y. Zhang, unpublished observations). Coupling restriction-digestion-based RR-MAB-seq allows 5fC/5caC mapping within genomic regions containing CpG-rich sequences (mostly gene promoters and some repeat sequences) ( Step 6C) 43 . It is important to note that the MspI enzyme used in standard RRBS only partially digests 5fC-containing C^CGG sites and completely fails to cut 5caCpGs, which will lead to underestimation of 5fC/5caC levels at the digestion sites 10 . Therefore, it is essential to choose a restriction enzyme (e.g., TaqαI) that efficiently cuts 5fC-and 5caC-modified CpGs. Finally, locus-specific MAB-seq or caMAB-seq analysis of regions of interest can be performed using appropriately designed PCR primers (Box 3). there is a clear trend that harsher conditions lead to more side reactions such as unintended deamination of 5mC and 5hmC. The 5mC conversion rate is assessed using methylated lambda DNA. The 5hmC/5fC/5caC conversion rate is assessed using synthetic 38-mer oligos. The actual conversion rate may slightly differ from the measured conversion rate, as the methylated lambda DNA and synthetic oligos may not be perfect. There are potentially two major sources of false positive signals: (i) unmethylated CpG sites that were not methylated by M.SssI; and (ii) bisulfite-treatment-induced deamination of 5mC and 5hmC. To statistically account for both sources of false positive signals, we modeled these presumably stochastic events with a binomial distribution X ~ B(N, p) (where random variable X follows binomial distribution B with parameters N and p, N is the sequencing coverage (N T + N C ) at a given CpG site and p is the probability of detecting false positive signals, which is the sum of both the failure rate of M.SssI and the deamination rate of 5mC) 40 . By using unmethylated lambda DNA as an internal spike-in control, we can experimentally determine p for every experiment (in our published study, we used 2.04% as p, which was averaged from multiple genome-scale MAB-seq experiments 40 ) and calculate the probability of whether raw MAB-seq signals (N T /(N C + N T )) are significantly higher than would be expected by chance. A notable caveat for this statistical filtering strategy is that deamination of 5hmC cannot be directly accounted for. However, given that the 5hmC modification level within CpGs generally ranges from 10 to 30% and the deamination rate of 5hmC in our optimized Box 2 | 5hmC/5fC/5caC-modified oligo spike-in for validating experimental conditions • tIMInG 2 d
1. Combine 250 pg of modified oligo with 250 ng of carrier genomic DNA. 2. When testing caMAB-seq, perform Step 6C(ii-ix). When testing MAB-seq, perform Step 6C(v-ix). 3. Perform bisulfite conversion according to the protocol in Step 6A(xiv-xvi). 4. Amplify the bisulfite-converted oligo using NEBNext multiplex oligo for Illumina, purify the amplified DNA and perform Illumina sequencing. A few thousand reads are sufficient for the purpose of quality control. 5. After sequencing data have been obtained, align the reads to the oligo template sequence. Non-CpG sites are expected not to be methylated, whereas 5hmC/5fC/5caC-modified CpG sites should behave as expected (table 1).
Box 3 | Locus-specific MAB-seq and caMAB-seq experiment • tIMInG 3 d
1. Spike 0.25% (wt/wt) lambda DNA into the genomic DNA of interest. 2. When testing caMAB-seq, perform Step 6C(ii-ix). When testing MAB-seq, perform Step 6C(v-ix). 3. Perform bisulfite conversion according to the protocol in Step 6A(xiv-xvi). 4. Amplify regions of interest by PCR using primers designed for bisulfite-converted genomic DNA. Programs such as methprimer (http://www.urogene.org/cgi-bin/methprimer/methprimer.cgi) can facilitate the BS-PCR primer design. We recommend choosing primers that generate PCR amplicons between 200 and 500 bp. In addition, amplify a region from lambda DNA for spike-in controls. For each pair of primers, set up a 15-µl reaction using 2× KAPA HiFi Uracil+ HotStart ReadyMix. Using properly designed primers and sufficient starting material (we typically start with 250 ng of genomic DNA and use 1/20 of the bisulfite-converted DNA as a template for each BS-PCR reaction), 35-40 cycles of amplification should generate sufficient products for visualization on agarose gel. 5. Perform downstream analysis using either Sanger sequencing (option A) or Illumina sequencing (option B), depending on the experimental purpose and service availability. bisulfite conversion condition is quite small (3.2%), the chance of detecting deaminated 5hmC as 5fC/5caC is quite low (0.3-1%) at a given CpG site 40, 46 . Indeed, when raw MAB-seq signals for called CpGs in Tdg-depleted cells are compared with those in wild-type cells (where 5hmC is present at similar levels), global MAB-seq signals in Tdg mutant cells are two-to threefold higher than in wild-type cells within 5fC/5caC-enriched genomic regions 40 . In addition, we have shown that >90% of 5hmC-modified CpGs are nonoverlapping with 5fC/5caC-modified sites in mouse ESCs 40 . Together, these observations indicate that 5hmC is unlikely to contribute significantly to the false positive signals in MAB-seq.
To estimate the empirical false discovery rate (FDR) in calling 5fC/5caC-modified CpGs, the steps above are repeated on MABseq signals of a negative control sample. /path-to-bedtools/coverageBed -a <common 5× CpG bed file> -b <100 bp bin bed file> | awk -v OFS='\t' '{if ($4>=2) print $1, $2, $3, $4;}' > <bin with at least two 5× CpG sites> 4. For each genomic bin with more than two common 5× CpG sites, sum up the C and T counts from all the common 5× CpG sites in this bin. MAB-seq or caMAB-seq signals of this bin are calculated as (Sum(N T )/(Sum(N T ) + Sum(N C ))). 5. Identify 5fC/5caC-modified bins and assess empirical FDR using the approach described in Step 18 .
MaterIals

REAGENTS
Wild-type feeder-independent mouse ESC line E14TG2a (ATCC, cat. no. ATCC CRL-1821) ! cautIon The cell lines used in your research should be regularly checked to ensure that they are authentic and that they are not infected with mycoplasma. Cells of interest. We have used Tdg-depleted 42 • dNTP mix for RR-MAB-seq and RR-caMAB-seq Make dNTP mix stock solution with the following composition: 10 mM dATP, 1 mM dGTP and 1 mM dCTP. Dilute the stock solution ten times in nuclease-free water to a working solution (1 mM dATP, 0.1 mM dCTP and 0.1 mM dGTP) immediately before use, and add the indicated volume to achieve the final concentration. The stock solution can be stored at −20 °C for at least 6 months.  crItIcal TaqαI digestion generates 5′ CG overhang (5′-T^CGA-3′, where '^' denotes the cutting site); therefore, dCTP and dGTP are required for end repair. The high concentration of dATP is for 3′ dA-tailing after end repair (both processes are taking place in a single reaction). However, when other restriction enzymes generating different overhangs are used, the dNTP composition needs to be adjusted accordingly. Make the working solution each time before use, and do not store it. Methylated adaptors Dilute the forward and reverse oligos to 100 µM with nuclease-free water. Set up the following reaction to anneal the forward and reverse oligos: 10 µl of forward oligo, 10 µl of reverse oligo, 2.5 µl of water and 2.5 µl of NEBuffer 2. The thermal cycle for annealing is as follows: 94 °C for 10 min; slowly ramp down to 60 °C and hold for 10 min (1% ramp if using an Eppendorf thermal cycler, or similar rate (for example, 0.1 °C per second) if using other thermal cyclers); and then slowly ramp down to 4 °C and hold (using the same ramping rate as in the previous step). This will generate a 40 µM annealed adaptor. Dilute the annealed adaptor to 15 µM, make aliquots and store them at −20 °C. For RR-MAB-seq or RR-caMAB-seq adaptor ligation, dilute the adaptor stock (15 µM) 20 times with water to a working solution (0.75 µM), and add the indicated volume.  crItIcal Use LoBind tubes for all procedures to avoid loss of oligos during the preparation and storage, and do not stock diluted oligos. 5hmC/5fC/5caC-modified oligo Dilute the forward and reverse modified oligos (ssDNA) with nuclease-free water to 1 µg/µl. Set up the following reaction to anneal the forward and reverse oligos: 4 µl of forward oligo, 4 µl of reverse oligo, 1 µl of water and 1 µl of NEBuffer 2. Perform oligo annealing using the same thermal program for annealing methylated adaptor oligos described above (the annealing reaction can be scaled down proportionally), which will give rise to 0.8 µg/µl 38-bp dsDNA. Take 2 µl (1.6 µg) for end repair and dA-tailing by NEBNext DNA Library Prep Master Mix Set for Illumina according to the manufacturer's instruction, with two modifications: the reaction is scaled down to 60% (60 µl for end repair and 30 µl for dA-tailings), and purification after end repair and dA-tailings is performed using the QIAquick nucleotide removal kit. Use the Qubit dsDNA HS kit to measure the concentration of the recovered 38-bp dsDNA, and ligate it to the methylated adaptor with a DNA:adaptor molar ratio of 1:10 (the ligation reaction is set up in 30 µl using the quick T4 ligase provided in the library preparation kit 
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To better mimic the metabolic milieu in vivo, maintain mouse ESCs in culture medium containing 100 µg/ml (final concentration) of vitamin C (VC) for 60 h.  crItIcal step Because VC is present at a relatively high level in both embryonic and adult mouse tissues 62 and positively regulates catalytic activity of TET enzymes 63, 64 , it is recommended that a physiologically relevant amount of VC be supplemented to the cell culture medium either transiently or long-term.
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At ~70% confluency, aspirate the medium and wash the cells with 1× DPBS. Aspirate DPBS and add sufficient 0.05% (wt/vol) trypsin to the culture dish (3 ml for each 10-cm dish). Incubate the mixture at 37 °C for 5 min.
4| After the cells have detached, add DMEM with 20% (vol/vol) FBS to inactivate the trypsin (6 ml of 10-cm dish), gently pipette to dissociate the cells and collect the cell suspension in a 15-ml Falcon conical tube.
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Centrifuge the cell suspension at 500g for 5 min at room temperature, and aspirate the supernatant and discard it.
Dna purification and M.sssI treatment 6| Prepare genomic DNA for different scales of analysis, and perform enzymatic treatment using CpG DNA methyltransferase M.SssI to protect unmodified CpGs in the genome from bisulfite conversion. Below are protocols for base-resolution mapping of 5fC/5caC using whole genomic DNA (option A: WG-MAB-seq), chromatin-immunoprecipitated DNA (option B: ChIP-MAB-seq) and enzyme-digested genomic DNA (option C: RR-MAB-seq). WG-MAB-seq (option A) provides an unbiased view of 5fC/5caC distribution across the entire genome. ChIP-MAB-seq (option B) using antibody to specific histone marks (e.g., histone 3 lysine 4 monomethylation (H3K4me1) or H3K27me3) can preferentially enrich genomic regions that contain relatively high levels of 5fC/5caC (e.g., poised promoters and active enhancers), and thus it requires less sequencing effort than WG-MAB-seq. Enzymatic-digestion-based RR-MAB-seq (option C) provides an approach to enrich CpG-rich promoters and repeat sequences. In option C, we also describe procedures combining caMAB-seq with the enzymatic-digestion-based strategy for genome-scale 5caC mapping (RR-caMAB-seq). Mix them well and incubate the reaction at 37 °C for 4 h. ? trouBlesHootInG (xv) Perform the bisulfite conversion reaction on a thermal cycler using the following thermal cycling program. require separate optimizations. To experimentally estimate the fragment size range, add 150 µl of elution buffer to 50 µl of sheared chromatin and reverse-cross-link the sample by incubating the tube at 65 °C overnight. Purify the DNA ( Step 6B(ix-xiv)) and examine the DNA fragment size by standard agarose gel electrophoresis or using Agilent Bioanalyzer. (vi) Measure chromatin concentration using NanoDrop (concentration (µg/ml) is estimated by (OD 260 × 50 × dilution factor). Dilute the chromatin to the concentration of 500 µg/ml in ChIP lysis buffer and aliquot 500 µg of chromatin (in 1 ml) for each ChIP sample. (vii) Add 100 µl of 10% (vol/vol) Triton X-100 to 500 µg chromatin (in 1 ml) immediately before immunoprecipitation.
Perform immunoprecipitation overnight at 4 °C by adding 50 µl of antibody-conjugated Dynabeads from Step 6B(iii).  crItIcal step Optimal immunoprecipitation conditions need to be separately determined for other antibodies. (viii) Wash DNA-protein complexes with 1 ml of RIPA buffer five times and with 1 ml of TE-50 mM NaCl once. To wash the sample, first invert the tubes several times and then place the sample tubes on a rocking platform for 2 min. Place tubes on a magnetic rack for 1 min to collect beads each time (until the solution becomes clear). After the final wash, centrifuge it at 1,000g for 3 min at 4 °C to pellet the magnetic beads, and discard TE-50 mM NaCl buffer. step Step 6C(ii-iv) is specifically for caMAB-seq. For the standard MAB-seq method, skip Step 6C(ii-iv) and start from Step 6C(v) using 250 ng of genomic DNA mixed with 0.625 ng of unmethylated lambda DNA (0.25% (wt/wt) spike-in).
(i) Purify genomic DNA from cultured cells as in Step 6A(i, ii).  crItIcal step For RR-MAB-seq-based simultaneous mapping of 5fC/5caC, jump to Step 6C(v). (xi) Set up an end-repair reaction by adding 2 µl of end-prep mix (prepared as follows) to the 18-µl mixture from Step 6C(x). Incubate the mixture at 37 °C for 40 min, and then subject to heat inactivation at 75 °C for 15 min.  crItIcal step To avoid potential ligation between methylated adaptors (which leads to unwanted adaptor dimers in the final library), we recommend adding the ligation mix in a step-wise manner as described above and mixing the reaction immediately after the T4 ligase is added. (xiii) Add 10 µl of nuclease-free water to the 25-µl ligation reaction mixture from Step 6C(xii). Perform bisulfite conversion and DNA purification using the Qiagen Epitect bisulfite kit as in Step 6A(xiv-xvi) with minor modifications in reaction composition as below: ? trouBlesHootInG 9| Purify library preparative PCR products with SPRI beads using option A for DNA from WG-MAB-Seq ( Step 6A) and ChIP-MAB-Seq (Step 6B) or using option B for DNA from RR-MAB-Seq or RR-caMAB-seq (Step 6C). trim_galore --fastqc --gzip --length 36 <raw.fastq.gz> (B) rr-MaB-seq or rr-caMaB-seq (i) Trim raw sequencing reads for Illumina adaptor sequences, low-quality bases and experimentally introduced 3′ CG using Trim Galore. Example command:
trim_galore --fastqc --gzip --three_prime_clip_R1 2 --length 36
<raw.fastq.gz>  crItIcal step During the end repair following TaqαI digestion, an unmodified CG is experimentally introduced at the 3′ end of the fragments, and it will be sequenced as TG after bisulfite conversion. To ensure that this artificial CG does not interfere with the analysis, after adaptors and low-quality bases are trimmed, an additional two bases at the 3′ end are trimmed from all reads.  crItIcal step In this case, we keep only reads that are no less than 36 bp in length after trimming. This cutoff can be adjusted for sequencing libraries with different read lengths.
13|
Align trimmed reads to the bisulfite-converted reference genome using the Bismark program. The reference genome sequences (e.g., mm9.fasta plus lambda.fasta) need to be first bisulfite-converted and indexed in silico.
Example command:
/path-to-bismark/bismark_genome_preparation --bowtie2 -path_to_bowtie <bowtie2 folder> --verbose <genome folder>
Once the bisulfite-converted reference genome index for Bismark/Bowtie2 has been generated, use the following command line to map trimmed reads:
/path-to-bismark/bismark --bowtie2 --path_to_bowtie <bowtie2_folder> - 
VALIDATION_STRINGENCY=SILENT CREATE_INDEX=true
These commands will generate a sorted BAM file containing only monoclonal reads.  crItIcal step Because restriction digestion instead of random shearing is used for fragmenting genomic DNA in RRBSbased experiments, skip this step for RR-MAB-seq or RR-caMAB-seq analysis. This command will generate a compressed bedgraph file, <bismark.cov.gz>, which can be used to extract raw MAB-seq signals and sequencing coverage information for each CpG site in the genome. This bedgraph file contains six columns: <chromosome>, <start position>, <end position>, <percentage of C>, <number of C> and <number of T>.  crItIcal step Because the samples are spiked in with unmethylated lambda DNA, the M.SssI methylase efficiency can be estimated from the methylation level within CpG dinucleotides of lambda DNA.  crItIcal step For downstream analysis, we recommend using CpG sites with at least 5× coverage, because some low-coverage CpG sites arise from wrong alignment or other unwanted situations. This command will generate a .tdf file for visualizing raw MAB-seq signals in the IGV browser (Fig. 5) 40 . downstream analysis. Obtain SNP information from Sanger Institute (https://www.sanger.ac.uk/sanger/Mouse_SnpViewer/ rel-1303) 65 and create a bed file summarizing all the genomic CpG sites containing SNPs (at C, G or both). Exclude these SNP-containing CpG sites using the intersectBed command from the BEDTools. Example command:
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/path-to-bedtools/intersectBed -a <Unfiltered bed file> -b <SNP-containing CpG bed file> -v > <Filtered bed file>  crItIcal step If WG-MAB-seq or ChIP-MAB-seq data sets are of sufficient sequencing depth (e.g., at least ten reads per strand), de novo SNPs overlapping with annotated CpG sites in the reference genome can be identified and removed with the BisSNP program. In the case of RR-MAB-seq and RR-caMAB-seq, only a small proportion of the CpG sites are covered in both positive and negative strands. Thus, de novo SNP detection, which relies on sequencing information obtained from both strands, will not remove all the SNPs.  crItIcal step In addition to SNP filtering, we recommend removing CpG sites with unusually high levels (for instance, CpGs in 80% reads are sequenced as TpGs) of raw MAB-seq signals (N T /(N T + N C ) in both the negative control (e.g., Dnmt1/3a/3b-knockout mouse ESCs) and the sample of interest. It is possible that these annotated CpG sites present in the reference genome could be mutated (e.g., C-to-T) in the sample.
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To identify CpG sites modified by a significant level of 5fC/5caC, we use the binomial distribution (N as the sequencing coverage (N T + N C ) and p as the probability of detecting false positive signals (the sum of the M.SssI methylase failure rate and the deamination rate of 5mC)) to assess the probability of observing N T or greater by chance. Example R command:
df: a data frame (df) containing two columns: the first one (x [1] ) is the number of T reads and the second one (x [2] ) is the total number of reads (C + T)). p: the probability of detecting false positive signals (we used 2.04% in our published study 40 ).
To estimate the empirical FDR of calling 5fC/5caC-modified CpGs, calculate the above statistics at each of the common CpGs in negative control samples (Dnmt1/3a/3b-knockout or Tet1/2/3-knockout cells) in which true 5fC/5caC signals are absent. The empirical FDR for a given P value cutoff is the number of called CpGs in negative controls divided by the number detected in the sample of interest. For RR-MAB-seq and RR-caMAB-seq analysis, 5fC/5caC-modified sites identified using the binomial-distribution-based P value cutoff approach can be further filtered by a numeric cutoff (for example, N T /(N T + N C ) should be at least 10%). In our hands, applying this additional numeric filter to RR-MAB-seq and RR-caMAB-seq data sets allows comparatively low FDR without compromising the detection sensitivity. For data sets with low sequencing depth or from cell types with relatively low levels of 5fC/5caC, analyzing genomic bins (divide genome into 100-bp bins) instead of single nucleotides may identify 5fC/5caC-marked regions with increased accuracy and sensitivity (Box 4). This is probably because true 5fC/5caC signals tend to cluster together, whereas false positive signals tend to disperse randomly in the genome (at least in mouse ESCs). Identification of 5fC/5caC-enriched genomic regions via a binning strategy is conceptually similar to the identification of differentially methylated regions in WGBS or RRBS analysis. Therefore, other tests (e.g., Fisher exact test) can be used as alternatives to the binomial-distribution-based test.
? trouBlesHootInG Troubleshooting advice can be found in table 2. If the Epitect bisulfite kit is used, the dissolved bisulfite mix can be stored at −20 °C and used within a month; however, avoid freezing/thawing more than once. DNA protection buffer and buffer BD should be stored at 4 °C and, ideally, replaced every 6 months When using kits other than the Qiagen Epitect bisulfite kit, test the protocol first using synthetic oligos and lambda DNA to make sure that 5fC is efficiently converted and that 5mC and 5hmC are not wrongly deaminated be uniquely aligned to the mouse genome. When two biologically independent sequencing libraries are combined (~500 million uniquely mapped and monoclonal reads), >95% of CpG dyads (out of a total of ~21 million CpG dyads) in the mouse genome can be covered with an average of 28× coverage per CpG dyad (combine both strands). Under this sequencing coverage, ~34 million CpGs (~80% of a total of ~42 million CpGs) can be covered by at least five times per strand. For ChIP-MAB-seq, we typically sequence ~100 million reads (100 bp single-end) per sample. Approximately 80% of reads can be uniquely mapped to the mouse genome after quality filtering. Under this sequencing depth, 3-4 million CpG dyads can be covered by at least five times per CpG dyad. For RR-MAB-seq or RR-caMAB-seq analysis, we usually sequence ~30 million reads (100 bp single-end) per library. After adaptor trimming and filtering of low-quality or short reads, ~45% of the reads can be mapped uniquely to the reference genome using the parameters specified in the data analysis part, giving rise to ~12 million uniquely mapped reads. Under this sequencing depth, ~1 million CpG sites are covered by at least five times per CpG (on each strand).
statistical calling of 5fc/5cac-modified cpGs
In our published study 40 , WG-MAB-seq analysis of Tdg-depleted and VC-treated (60 h) mouse ESCs identified 675,325 5fC/5caC-modified CpGs (2.7% out of 24,872,637 CpGs with coverage of ≥10, using a stringent P value cutoff leading to an FDR <5%). With a similar FDR cutoff (<5%) and sequencing depth filtering (≥10 per CpG dyads), H3K4me1-MAB-seq analysis identified 127,576 (7.6% out of 1,670,036 CpG dyads with N ≥ 10) 5fC/5caC-modified CpG dyads in VC-treated, Tdg-depleted mouse ESCs (shTdg + VC). The higher percentage of 5fC/5caC-modified CpG identified in H3K4me1-marked genomic domains is expected, as 5fC and 5caC are preferentially enriched in these gene regulatory regions. Choosing the P value cutoff partly depends on the purpose of the downstream analyses. For a biological sample with much less 5fC/5caC (e.g., wild-type mouse ESCs), a much higher sequencing depth is required to distinguish true 5fC/5caC signals from background. To partially circumvent the requirement of ultra-high sequencing depth, one can analyze MAB-seq data sets by combining individual CpG sites into genomic bins (e.g., 100-bp intervals) and by using statistical calling with a less stringent FDR cutoff, which may provide a lower-resolution map of 5fC/5caC-modified CpGs in cell types with lower levels of 5fC/5caC. Similarly, RR-MAB-seq data sets tend to generate a higher FDR at a given P value for the following two reasons. First, PCR duplicates cannot be removed when using a standard RRBS strategy, which increases the likelihood of overly amplifying random background signals. Second, RRBS preferentially covers GC-rich regions that are generally depleted of 5fC/5caC (at least in mouse ESCs). These potential problems can be partly solved by adopting a unique molecule identifier (UMI)-based RRBS approach 66 to remove PCR duplicates, and by using other restriction enzymes that cover more 5fC/5caC-modified regions. 
